adenosine has been researched along with ACD-MPV in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Franklin, O; Ng, C; Petros, A; Pierce, C; Vaidya, M | 1 |
Fineman, JR; Oishi, P | 1 |
Aggoun, Y; Beghetti, M; Berner, M; da Cruz, E; Motti, A; Prina-Rousso, A; Rimensberger, PC; Tissot, C | 1 |
Konduri, GG | 1 |
Garcia, DC; Kazzi, NJ; Konduri, GG; Shankaran, S | 1 |
Lee, J; Patole, S; Whitehall, J | 1 |
2 trial(s) available for adenosine and ACD-MPV
Article | Year |
---|---|
Adenosine infusion for the management of persistent pulmonary hypertension of the newborn.
Topics: Adenosine; Administration, Inhalation; Drug Therapy, Combination; Humans; Infant, Newborn; Infusions, Intravenous; Nitric Oxide; Persistent Fetal Circulation Syndrome; Prospective Studies; Vasodilator Agents | 2004 |
Adenosine infusion improves oxygenation in term infants with respiratory failure.
Topics: Adenosine; Blood Pressure; Female; Heart Rate; Humans; Infant, Newborn; Infusions, Intravenous; Male; Oxygen; Persistent Fetal Circulation Syndrome; Pilot Projects; Respiration, Artificial; Respiratory Insufficiency; Vasodilator Agents | 1996 |
4 other study(ies) available for adenosine and ACD-MPV
Article | Year |
---|---|
Pharmacologic therapy for persistent pulmonary hypertension of the newborn: as "poly" as the disease itself.
Topics: Adenosine; Drug Therapy, Combination; Humans; Infant, Newborn; Nitric Oxide; Persistent Fetal Circulation Syndrome; Vasodilator Agents | 2004 |
Intravenous adenosine for refractory pulmonary hypertension in a low-weight premature newborn: a potential new drug for rescue therapy.
Topics: Adenosine; High-Frequency Ventilation; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Male; Nitric Oxide; Persistent Fetal Circulation Syndrome; Treatment Failure; Ultrasonography; Vasodilator Agents | 2006 |
Systemic and myocardial effects of ATP and adenosine during hypoxic pulmonary hypertension in lambs.
Topics: Adenosine; Adenosine Triphosphate; Animals; Animals, Newborn; Disease Models, Animal; Heart; Humans; Infant, Newborn; Oxygen; Oxygen Consumption; Persistent Fetal Circulation Syndrome; Sheep | 1994 |
Adenosine infusion in the management of a micropremi neonate with pulmonary hypertension.
Topics: Adenosine; Anti-Inflammatory Agents, Non-Steroidal; Ductus Arteriosus, Patent; Fatal Outcome; Humans; Indomethacin; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Infusions, Intravenous; Male; Persistent Fetal Circulation Syndrome; Positive-Pressure Respiration; Vasodilator Agents; Ventilator Weaning | 1998 |